Bank of Nova Scotia Grows Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Bank of Nova Scotia grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 92.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,141 shares of the medical instruments supplier’s stock after buying an additional 7,747 shares during the period. Bank of Nova Scotia’s holdings in DENTSPLY SIRONA were worth $574,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Norges Bank acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth about $114,207,000. Nuance Investments LLC boosted its position in DENTSPLY SIRONA by 30.4% in the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after buying an additional 2,702,457 shares during the last quarter. Cooke & Bieler LP increased its holdings in DENTSPLY SIRONA by 18.3% in the 4th quarter. Cooke & Bieler LP now owns 7,061,910 shares of the medical instruments supplier’s stock worth $251,333,000 after buying an additional 1,092,922 shares during the period. Jennison Associates LLC purchased a new position in DENTSPLY SIRONA during the 4th quarter worth approximately $20,741,000. Finally, Invesco Ltd. lifted its stake in DENTSPLY SIRONA by 9.0% during the 3rd quarter. Invesco Ltd. now owns 5,160,394 shares of the medical instruments supplier’s stock valued at $176,279,000 after acquiring an additional 428,229 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts recently issued reports on XRAY shares. The Goldman Sachs Group reduced their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a report on Monday, May 6th. Evercore ISI lowered their target price on DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating on the stock in a research note on Friday, May 3rd. lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a report on Friday, May 3rd. Finally, SVB Leerink started coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective on the stock. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to, the stock presently has an average rating of “Moderate Buy” and an average price target of $35.22.

Check Out Our Latest Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $27.69 on Friday. The company has a fifty day moving average of $29.45 and a two-hundred day moving average of $32.35. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.27 and a fifty-two week high of $41.65. The stock has a market capitalization of $5.75 billion, a PE ratio of -62.93, a P/E/G ratio of 1.24 and a beta of 1.04. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The firm had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same period last year, the company posted $0.39 EPS. DENTSPLY SIRONA’s quarterly revenue was down 2.6% compared to the same quarter last year. As a group, research analysts forecast that DENTSPLY SIRONA Inc. will post 2.03 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Shareholders of record on Friday, June 28th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.64 dividend on an annualized basis and a yield of 2.31%. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 3,577 shares of DENTSPLY SIRONA stock in a transaction dated Friday, May 31st. The stock was acquired at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the transaction, the director now directly owns 58,374 shares of the company’s stock, valued at $1,631,553.30. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.52% of the stock is currently owned by corporate insiders.


(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with's FREE daily email newsletter.